The decision to expand the development plan follows recently reported promising preclinical findings demonstrating that ...

The market regulator has once again extended the deadline for registered entities (REs) to adopt Cybersecurity and Cyber Resilience Framework (CSCRF), except for market infrastruc ...

SEBI extends compliance deadline for Cybersecurity and Cyber Resilience Framework until June 30, 2025, except for certain entities.

Sebi has extended the deadline for regulated entities to adopt a cybersecurity framework to June 2025, citing requests for ...

These days, along with the relief of having a stable job, comes a load of added stress- with work pressure mounting up day on ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Good morning, Mike Shildt got to break out one of his favorite expressions one game into the season, and he did not waste any ...

Markets regulator Sebi on Friday extended the timeline by three months till June for regulated entities to adopt and implement cybersecurity and cyber resilience framework.

With a flurry of financial changes set to take effect in April, it is important for investors to keep a close eye on the ...

Sebi has extended the deadline by three months for regulated entities to implement a cybersecurity and cyber resilience ...

QTX3544 is an oral, G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor currently being evaluated in a Phase 1 clinical trial in patients with KRASG12V mutations. The mitogen-activated ...